BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19212288)

  • 1. [Five year survival for lung cancer patients managed in general hospitals].
    Grivaux M; Zureik M; Marsal L; Asselain B; Peureux M; Chavaillon JM; Prud'homme A; Carbonnelle M; Goarant E; Maury B; Bedossa A; Blanchon F
    Rev Mal Respir; 2009 Jan; 26(1):37-44. PubMed ID: 19212288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year survival for lung cancer patients managed in general hospitals.
    Grivaux M; Zureik M; Marsal L; Asselain B; Peureux M; Chavaillon JM; Prudhomme A; Carbonnelle M; Goarant E; Maury B; Bedossa A; Blanchon F
    Rev Mal Respir; 2011 Sep; 28(7):e31-8. PubMed ID: 21943545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cohort KBP-2000-CPHG: Evaluation of factors influencing survival in lung cancer].
    Blanchon F; Grivaux M; Zureik M; Marsal L; Asselain B; Lebas FX; Orlando JP; Steenhouwer F; Benichou-Flurin M; Coëtmeur D; Collon T; David P; Delclaux B; Piquet J
    Rev Mal Respir; 2006 Apr; 23(2 Pt 1):165-71. PubMed ID: 16788443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of slight improvement in five-year survival in non-small-cell lung cancer over the last 10 years: Results of the French KBP-CPHG real-world studies.
    Debieuvre D; Locher C; Asselain B; Dayen C; Molinier O; Falchero L; Dujon C; Delclaux B; Grivaux M
    Bull Cancer; 2019 Apr; 106(4):283-292. PubMed ID: 30803715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [One-year survival improvement in lung cancer in France. Results of the prospective real life studies KBP-2000-CPHG and KBP-2010-CPHG].
    Grivaux M; Duvert B; Ferrer-Lopez P; Hominal S; Goarant E; Brichet-Martin A; Romand P; Fournier E; Asselain B; Debieuvre D
    Rev Pneumol Clin; 2016 May; 72(3):163-70. PubMed ID: 27113617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new face of non-small-cell lung cancer in men: Results of two French prospective epidemiological studies conducted 10 years apart.
    Debieuvre D; Oster JP; Riou R; Berruchon J; Levy A; Mathieu JP; Dumont P; Leroy-Terquem E; Tizon-Couetil V; Martin F; Grivaux M
    Lung Cancer; 2016 Jan; 91():1-6. PubMed ID: 26711927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index.
    Blanchon F; Grivaux M; Asselain B; Lebas FX; Orlando JP; Piquet J; Zureik M
    Lancet Oncol; 2006 Oct; 7(10):829-36. PubMed ID: 17012045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer.
    Martini N; Rusch VW; Bains MS; Kris MG; Downey RJ; Flehinger BJ; Ginsberg RJ
    J Thorac Cardiovasc Surg; 1999 Jan; 117(1):32-6; discussion 37-8. PubMed ID: 9869756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer among women in France. Analysis of the 904 French women with lung cancer included in the KBP-2000-CPHG study of the French College of General Hospital-based Pneumologists (CPHG).
    Grivaux M; Breton JL; Bombaron P; Kuntz P; Lebas FX; Mehdaoui A; Herman D; David P; Berruchon J; Delclaux B; Zureik M; Blanchon F;
    Lung Cancer; 2004 Sep; 45(3):279-87. PubMed ID: 15301868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of lung cancer cases diagnosed in an internal medicine department: from January 2001 to September 2006].
    Fernández V; Alonso JL; Munuera L; Moya JL; Lasa B; Suárez A; Gutiérrez J
    An Sist Sanit Navar; 2007; 30(3):353-62. PubMed ID: 18227892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [First treatment strategies in the 2 years following lung cancer diagnosis. ESCAP-2011-CPHG, a real-life study carried out in French general hospitals].
    Grivaux M; Goupil F; Asselain B; Blanchon F; Collon T; Coëtmeur D; Dayen C; Locher C; Molinier O; Martin F; Debieuvre D
    Rev Mal Respir; 2017 Nov; 34(9):991-999. PubMed ID: 29111174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors in unresectable lung cancer].
    Urata A
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2035-42. PubMed ID: 2840034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and clinical characteristics of 1433 patients with lung cancer.
    Mañé JM; Estapé J; Sánchez-Lloret J; Grau JJ; Palombo H; Agusti C; Mellado B
    Age Ageing; 1994 Jan; 23(1):28-31. PubMed ID: 8010167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of prognostic factors on the survival of lung cancer patients].
    Plieskiene A; Juozaityte E; Inciūra A; Jarusevicius L; Mazuolis D; Sakalauskas R
    Medicina (Kaunas); 2003; 39(3):278-85. PubMed ID: 12695642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lung cancer in women: clinical features and factors related to survival].
    Sen E; Kaya A; Erol S; Savas I; Gonullu U
    Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early mortality in lung cancer: French prospective multicentre observational study.
    Grivaux M; Debieuvre D; Herman D; Lemonnier C; Marcos JM; Crequit J; Vuillermoz-Blas S; Barre P; Saillour M; Martin F
    BMC Pulm Med; 2016 Apr; 16():45. PubMed ID: 27039176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition.
    Sculier JP; Chansky K; Crowley JJ; Van Meerbeeck J; Goldstraw P;
    J Thorac Oncol; 2008 May; 3(5):457-66. PubMed ID: 18448996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients.
    Chang GC; Tsai CM; Chen KC; Yu CJ; Shih JY; Yang TY; Lin CP; Hsu JY; Chiu CH; Perng RP; Yang PC; Yang CH
    J Thorac Oncol; 2006 Jul; 1(6):520-5. PubMed ID: 17409911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in older patients with advanced non-small cell lung cancer in China.
    Su Q; Sun YP; Liu YH; Li Z; Yang HY; Sun ZG; Cao BW; Jia JH
    Tumori; 2014; 100(1):69-74. PubMed ID: 24675494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.